Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 388

Similar articles for PubMed (Select 20826434)

1.

Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.

Lehéricy S, Hartmann A, Lannuzel A, Galanaud D, Delmaire C, Bienaimée MJ, Jodoin N, Roze E, Gaymard B, Vidailhet M.

Brain. 2010 Aug;133(Pt 8):2410-25. doi: 10.1093/brain/awq162.

2.

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M.

Brain. 2007 Mar;130(Pt 3):816-27. Epub 2007 Feb 15.

3.

Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.

Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB.

Neuroimage. 2004 Feb;21(2):714-24.

PMID:
14980574
4.

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.

Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C.

Brain. 2002 Apr;125(Pt 4):801-11.

5.

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

Tedeschi G, Litvan I, Bonavita S, Bertolino A, Lundbom N, Patronas NJ, Hallett M.

Brain. 1997 Sep;120 ( Pt 9):1541-52.

6.

Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.

Sajjadi SA, Acosta-Cabronero J, Patterson K, Diaz-de-Grenu LZ, Williams GB, Nestor PJ.

Brain. 2013 Jul;136(Pt 7):2253-61. doi: 10.1093/brain/awt118. Epub 2013 May 31.

7.

Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.

Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW.

Parkinsonism Relat Disord. 2002 Oct;9(1):39-54. Review.

PMID:
12217621
8.

The evolution of primary progressive apraxia of speech.

Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Schwarz CG, Reid RI, Spychalla AJ, Lowe VJ, Jack CR Jr, Whitwell JL.

Brain. 2014 Oct;137(Pt 10):2783-95. doi: 10.1093/brain/awu223. Epub 2014 Aug 11.

PMID:
25113789
9.

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ.

Arch Neurol. 2006 Jan;63(1):81-6.

PMID:
16401739
10.

Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.

Seppi K, Poewe W.

Neuroimaging Clin N Am. 2010 Feb;20(1):29-55. doi: 10.1016/j.nic.2009.08.016. Review.

PMID:
19959017
11.

Neuroimaging in Parkinsonism: a study with magnetic resonance and spectroscopy as tools in the differential diagnosis.

Vasconcellos LF, Novis SA, Moreira DM, Rosso AL, Leite AC.

Arq Neuropsiquiatr. 2009 Mar;67(1):1-6.

12.

Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study.

Wang J, Wai Y, Lin WY, Ng S, Wang CH, Hsieh R, Hsieh C, Chen RS, Lu CS.

J Magn Reson Imaging. 2010 Jul;32(1):69-75. doi: 10.1002/jmri.22229.

PMID:
20578012
13.

Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.

Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Kantarci K, Eggers SD, Jack CR Jr, Josephs KA.

Eur J Neurol. 2013 Apr;20(4):629-37. doi: 10.1111/ene.12004. Epub 2012 Oct 18.

14.

Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.

Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, Dichgans J, Klockgether T.

Ann Neurol. 1999 Jan;45(1):65-74.

PMID:
9894879
15.

Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.

Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W.

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):246-9.

16.

The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.

Camuzat A, Romana M, Dürr A, Feingold J, Brice A, Ruberg M, Lannuzel A.

Mov Disord. 2008 Dec 15;23(16):2384-91. doi: 10.1002/mds.22297.

PMID:
18785640
17.

The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.

Agosta F, Kostić VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M.

Eur J Neurosci. 2010 Aug;32(4):640-7. doi: 10.1111/j.1460-9568.2010.07304.x. Epub 2010 Jun 30.

PMID:
20597976
18.

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

Juh R, Kim J, Moon D, Choe B, Suh T.

Eur J Radiol. 2004 Sep;51(3):223-33.

PMID:
15294329
19.

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.

Brain. 2008 Oct;131(Pt 10):2690-700. doi: 10.1093/brain/awn195. Epub 2008 Sep 26.

20.

Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy.

Canu E, Agosta F, Baglio F, Galantucci S, Nemni R, Filippi M.

Mov Disord. 2011 Aug 1;26(9):1752-5. doi: 10.1002/mds.23739. Epub 2011 Apr 15.

PMID:
21500281
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk